--- title: 'Sr. Bioinformatics Scientist - Collaborations at Personalis, Inc' canonical: 'https://feeny.ai/job/sr-bioinformatics-scientist-collaborations-personalis-inc-fremont-6rd88mt391sv' type: 'job' last_seen: '2026-11-05' --- # Sr. Bioinformatics Scientist - Collaborations at Personalis, Inc - **Company:** Personalis, Inc - **Location:** Fremont, CA - **Posted:** 2026-10-08 - **Last confirmed live:** 2026-11-05 - **Apply:** https://job-boards.greenhouse.io/personalisinc/jobs/8017052003 ## Job description At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. Summary: The Senior Bioinformatics Scientist will work with a world-class, dynamic team of bioinformatics scientists, software engineers, and laboratory scientists, developing, testing, and applying cutting-edge cell-free and solid tumor cancer genomics products. Further, the Bioinformatics Scientist will be working alongside our collaboration teams, applying our cell-free solutions to large cancer patient cohorts and profiling patient response to therapy with our exome-scale solid tumor and cfDNA platforms. This position will directly contribute to a new generation of genomics-based precision-medicine products in immuno-oncology, cancer clinical trials, diagnostics, and therapeutics used by pharma, biotech, hospitals, and clinicians. Days onsite: Monday and Tuesday Responsibilities: - Plan, develop, and manage scientific collaborations, applying internally developed liquid biopsy and solid tumor products to detect somatic variants, neoantigens, and tumor escape mechanisms within high-profile and impactful partnerships - Build upon our novel cell-free platforms and products, including our NeXT Personal MRD liquid biopsy platform - Work cross-functionally to translate collaborative findings into actively developed cutting-edge products - Design and execute scientific projects and experiments focused on demonstrating the performance as well as research and clinical advantages our of cell-free platforms - Modeling and analysis of large, complex genomics datasets using cutting-edge methods to generate biological and clinical insights - Work with scientific teams to translate scientific findings into actively developed cutting-edge products - Publish results and present at conferences in exciting areas, including cell-free DNA, cancer genomics, and immuno-oncology Requirements: - Advanced degree (Ph.D.) in bioinformatics, genomics, or a related field - Experience managing, analyzing, and interpreting large impactful multi-participant projects - ## Experience with cancer liquid biopsy analysis - ## Experience with survival analysis - Proficiency with at least one common programming language (e.g., Python, R) - ## Experience with cancer genomics and variant detection - ## Experience publishing and presenting scientific results The hiring range for this position is $158,000 to $190,000 per year, which may factor in various geographic regions. The base pay actually offered will take into account internal equity and also may vary depending on the candidate’s geographic region, job-related knowledge, skills, and experience among other factors. Our full-time regular positions also include an annual performance-based bonus (or a sales incentive plan) and long-term incentive units (equity) provided as part of our compensation package, in addition to a full range of medical, financial, and/or other benefits, dependent on the level and position offered. Personalis is an equal opportunity employer and is committed to the full inclusion of all individuals. As part of this commitment, Personalis will ensure that persons with disabilities are provided with reasonable accommodations. If you need an accommodation to participate in the job application or interview process, to perform essential job functions, and/or to receive other benefits and privileges of employment, please let your recruiter know, if/when they contacts you. Protecting Our Candidates: At Personalis, we value your security. Please note that all official correspondence from our team will come exclusively from @[personalis.com](http://personalis.com) email addresses. We will never ask for personal financial information or conduct interviews over text or chat platforms. If you receive a suspicious request, it is likely a scam. We are committed to a safe recruitment experience and actively work with authorities to investigate and prosecute cyber crimes targeting our community. Personalis offers a competitive compensation package and benefits including medical, dental, vision, 401(k) match, ESPP, tuition reimbursement, sick/vacation time, commuter benefits/ EV charging stations, onsite gym, and wellness benefits. (For US only, benefits in other countries may vary.) #LI-KK1 #LI-Hybrid ## About Personalis, Inc ## Company Overview - **One-liner**: Personalis is a precision oncology company that transforms the active management of cancer through advanced, personalized genomic testing and ultra-sensitive circulating tumor DNA (ctDNA) detection. - **Entity Type**: Public (NASDAQ: PSNL) - **Headquarters**: Fremont, California, United States - **Founded**: 2011 - **Founders**: Not publicly listed as a single founder; the company was founded by a team of genomics experts from Stanford University and the broader life sciences community. ## Core Business - **Primary industry/industries**: Precision Oncology, Biotechnology, Genomic Testing, Molecular Diagnostics - **Target customers**: B2B — primarily oncologists, hospitals, cancer centers, and biopharmaceutical companies (for drug development and clinical trials) - **Mission or purpose statement**: "Revealing the unique genetic signatures of solid tumors" to enable earlier cancer detection, more effective treatment selection, and better patient outcomes. ## Products & Services - **NeXT Personal Dx**: An ultra-sensitive, personalized blood test that detects circulating tumor DNA (ctDNA) to monitor for cancer recurrence. It can detect as little as 1 tumor DNA fragment in 1 million normal cells, often identifying recurrence months to years before standard imaging. Approved for Medicare reimbursement for breast cancer (Q4 2025) and non-small cell lung cancer (Q1 2026) surveillance. - **NeXT Dx**: A comprehensive genomic profiling test for solid tumors, used to guide therapy selection. Approved for Medicare reimbursement (Q1 2024). - **NeXT Personal (Pharma Services)**: A highly sensitive ctDNA assay used by biopharma partners for clinical trials, enabling early detection of molecular residual disease (MRD) and monitoring of treatment response. - **Advanced Tumor Profiling**: Ultra-comprehensive genomic profiling services for biopharma partners to optimize patient selection and biomarker strategy in drug development. ## Market Standing - **Valuation/Market Cap**: ~$872.9 million (as of mid-2026) - **Key Metric**: Annual Revenue — $69.6 million (2025); 2026 guidance of $78–80 million total company revenue, with NeXT Personal strategic revenue estimated at $30–32 million. - **Notable Investors/Partners**: Merck (post-IPO equity investment of $50M in Dec 2024), Tempus (post-IPO equity investment of $36.1M in Aug 2024), Lightspeed Venture Partners (led Series C), Myriad Genetics (non-exclusive IP access agreement, 2024). - **Growth Signals**: 26% revenue growth rate at the midpoint of 2026 guidance; over 25,000 tests delivered to date; Medicare reimbursement approvals for NeXT Personal Dx in breast and lung cancer; strong cash position of ~$233 million with no debt; 16% year-over-year headcount growth. ## Competitive Advantages - **Ultra-Sensitive Technology**: NeXT Personal Dx can detect 1 tumor DNA fragment in 1 million normal cells, offering a "1-in-a-million" sensitivity that often detects recurrence 5–15 months earlier than standard imaging. - **Personalized Approach**: The test identifies up to 1,800 unique DNA markers from each patient's tumor, creating a truly personalized liquid biopsy. - **Strong IP Moat**: Over 70 patents worldwide and 38 U.S. patents, providing robust legal protection for their technology. - **Proven Reimbursement Path**: Successfully navigated Medicare coverage for both NeXT Dx and NeXT Personal Dx, a critical barrier to entry in the U.S. diagnostics market. - **Strategic Partnerships**: Deep collaborations with biopharma leaders (Merck, Tempus) and a strong network of academic and clinical partners. ## Strategic Focus - **Accelerating Clinical Test Volume**: Driving adoption of NeXT Personal Dx through Medicare reimbursement and expanding clinical evidence across breast, lung, colorectal, and other cancers. - **Expanding Evidence Base**: Conducting studies in breast, colorectal, and lung cancer, as well as immunotherapy monitoring, to broaden clinical utility and payer coverage. - **Biopharma Partnerships**: Growing the pharma services business by enabling drug developers with ultra-sensitive MRD and therapy selection assays. - **Operational Efficiency**: Scaling clinical test volume to improve gross margins and drive toward profitability, supported by a strong cash position. ## Why Work Here - **Mission-Driven Work**: Employees directly contribute to transforming cancer care by enabling earlier detection and more personalized treatment for patients. - **Growth Trajectory**: The company is in a high-growth phase (26% revenue growth guidance for 2026), with expanding Medicare coverage and a strong pipeline of clinical studies. - **Culture & Environment**: Rated 3.6/5.0 on employer review sites, with particular strengths in compensation (3.6) and culture (3.6). The company values scientific rigor and innovation. - **Work Policy**: Based in Fremont, CA, with a second office in Menlo Park. The company operates in a hybrid/office environment typical of a biotech R&D and lab operations setting. - **Notable Perks**: Opportunity to work at the cutting edge of genomics and precision oncology; strong IP and scientific culture; involvement in high-impact clinical studies and publications. - **Engineering & Science Culture**: Heavy emphasis on bioinformatics, assay development, and clinical science. The workforce is heavily weighted toward medical, technical, and research roles. ## Sources 1. [Personalis.com](https://www.personalis.com/) 2. [Personalis Careers Page](https://job-boards.greenhouse.io/personalisinc) 3. [Personalis Company Page](http://www.personalis.com/company/) 4. [LinkedIn - Personalis](https://www.linkedin.com/company/personalis-inc) 5. [Personalis Investor Presentation (May 2026)](https://investors.personalis.com/static-files/3c11319a-f39a-4a31-bcd3-1702b82adf4d) ## Other roles at Personalis, Inc - [CGMBS Training Program 2027 (Internal Applicants Only)](https://feeny.ai/job/cgmbs-training-program-2027-internal-applicants-only-personalis-inc-fremont-qvv7cqana07q) — Fremont, CA - [Billing Associate](https://feeny.ai/job/billing-associate-personalis-inc-fremont-0fta65wqknfv) — Fremont, CA - [Medical Science Liaison](https://feeny.ai/job/medical-science-liaison-personalis-inc-remote-1nd2fjjjjsty) - [Clinical Lab Scientist 1 (Temp)](https://feeny.ai/job/clinical-lab-scientist-1-temp-personalis-inc-fremont-99w23twhtnrw) — Fremont, CA - [Histotechnician, 2nd Shift (Mon - Fri)](https://feeny.ai/job/histotechnician-2nd-shift-mon-fri-personalis-inc-fremont-61xnv56zwvvj) — Fremont, CA - [Sample Accessioner 1 (Temp)](https://feeny.ai/job/sample-accessioner-1-temp-personalis-inc-fremont-gtpdcyyzjnvj) — Fremont, CA - [Product Development - Research Associate 2 / Sr. Research Associate](https://feeny.ai/job/product-development-research-associate-2-sr-research-associate-personalis-inc-x1c365e7znjc) — Fremont, CA - [Sr. Software Engineer, Clinical Software](https://feeny.ai/job/sr-software-engineer-clinical-software-personalis-inc-fremont-337dve7tg923) — Fremont, CA - [Clinical Lab Scientist Supervisor, Lab Operations, 2nd & 3rd Shifts](https://feeny.ai/job/clinical-lab-scientist-supervisor-lab-operations-2nd-3rd-shifts-personalis-inc-547432qdqffb) — Fremont, CA - [Clinical Lab Scientist 1](https://feeny.ai/job/clinical-lab-scientist-1-personalis-inc-fremont-psc5xcynr99g) — Fremont, CA